Diagnosis of pneumocystis pneumonia is based on identifying Pneumocystis carinii cytochemically in material from the lung. The silver methenamine staining methods most commonly used are technically difficult and lack specificity. The diagnostic value of immunocytological identification of the parasite was evaluated by using mouse monoclonal antibody 3F6, specific for human pneumocystis, to identify P carinii in bronchoalveolar lavage fluid and sputum by immunofluorescence and was compared with that of other variables.
Introduction
Pneumocystis carinii has been increasingly recognised as an important cause of opportunistic infection in immunodeficient hosts. Pneumocystis pneumonia is the most common treatable infection in patients with AIDS, occurring in over 60%. ' The diagnosis is based on visual detection of the parasite in material from the lung. Open lung biopsy was previously the preferred procedure for recovering the organism but has been replaced by bronchoscopy combined with bronchoalveolar lavage or transbronchial biopsy, or both, which have proved to be as sensitive and less traumatic.23 Recent evaluation of cytochemical staining of specimens of induced sputum showed a sensitivity of about 55%.4 5 Several cytological stains have been used for identifying pneumocystis.6 Different modifications of Gomori's silver methenamine staining method have been commonly used,7 but these may be technically difficult, the microscopic examination may be time consuming, and the presence of, for example, silver stained fungi and argyrophilic tissue elements may cause diagnostic problems.78 These problems together with the increased demand for diagnosis of pneumocystis pneumonia and for safe handling of samples from patients with human immunodeficiency virus (HIV) require that the method of detection be improved. Immunocytological staining of pneumocystis in bronchoalveolar lavage fluid and lung tissue from experimentally infected rats was shown to be better than cytochemical methods,9 1' the advantages including earlier detection of the parasite, more rapid enumeration, and detection of small trophozoites and free forms. Monoclonal antibodies for specifically identifying pneumocystis in material from the lung have therefore been developed. " We have developed a mouse monoclonal antibody to human pneumocystis (3F6) that can detect the parasite in fixed samples in which HIV has been inactivated.'2 13 Immunocytological staining with this antibody did not show any reactivity with cryptosporidium, Aspergillus fumigatus, six Candida species, or several protozoa.
The aim of this study was to evaluate the ability of this monoclonal antibody to detect the parasite in bronchoalveolar lavage fluid and sputum that had been fixed with ethanol. The diagnostic value of clinical symptoms, chest x ray films, and the presence of antibodies to pneumocystis was also evaluated.
Patients and methods
We Bronchoalveolar lavage-The bronchial tree was examined to subsegmental level by fibreoptic bronchoscopy and the bronchoscope wedged into the most suitable subsegment. A total of 150-200 ml lukewarm saline at 37°C was instilled in 50 ml aliquots, and each aliquot was aspirated. Usually 50-100 ml of fluid was recovered.' Additional material for cytological examination was obtained simultaneously by bronchial brushing, and transbronchial biopsy specimens were taken in many cases.
Sputum collection-Routine sputum samples were collected (if necessary with the help of a physiotherapist) and treated with an equal amount of 6-5 mM dithiothreitol (Behring Diagnostics). An equal volume of 50% (v/v) ethanol was added before the specimen was transported to the laboratory. '5lb Induced sputum was obtained after patients had inhaled a mist of saline generated by a nebuliser for about 10 minutes.4 The samples were treated as described above.
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Pneumocystis was identified in the sputum of patients positive for HIV antibody by immunofluorescence in 14 of 43 episodes of suspected pneumocystis pneumonia and in three of these 14 by staining with silver methenamine. The samples from the 29 remaining episodes yielded negative results by both methods. Induced sputum yielded pneumocystis in six of the 10 episodes for which specimens were available. Routine sputum samples obtained in the remaining 33 episodes showed the organism in eight cases. In 17 of the 25 patients in the study group sputum was collected within two weeks before or two days after lavage. In only four of the 17 induced sputum was obtained. Positive results were obtained in both sputum and lavage fluid in eight patients, in lavage fluid but not sputum in six, and in neither in three. By comparison with the examination of lavage fluid the sensitivity of examination of sputum was 57% (8/14) and the negative predictive value (true negatives/(true+false negatives)) 33% (3/9).
Discussion
Immunofluorescence staining with 3F6 monoclonal antibody seemed more sensitive than the conventional cytochemical stain in identifying pneumocystis in bronchoalveolar lavage fluid, thus confirming our preliminary results.'2 Two samples of lavage fluid yielded positive results on immunofluorescence but negative results on staining with silver methenamine. This may be due to the ability of 3F6 monoclonal antibody to detect free trophozoites and those stages of pneumocystis cysts without a well developed cyst wall (figure) and is consistent with results of immunocytochemical studies on experimentally infected rats.910 Giemsa staining also failed to show pneumocystis in these two samples, although our experience with this stain is limited, and the method is not optimal when applied to specimens that have been fixed with ethanol. The greater ease of detecting pneumocystis by immunofluorescence is a strong point in its favour.
The chest x ray findings within one week before bronchoalveolar lavage correlated well with the findings on microscopy and confirmed results of a study of chest x ray findings at the time of fibreoptic bronchoscopy.'8 This is in contrast, however, to the reputedly poor diagnostic value of chest x ray films when evaluated on admission. '9 In agreement with previous studies the clinical symptoms and the presence of circulating antibodies to pneumocystis did not seem to be of diagnostic value."2'
Immunofluorescence was superior to the silver methenamine method for detecting pneumocystis in sputum, owing to the dominance of trophozoites and immature cysts in sputum. Pneumocystis was detected more commonly in induced sputum than in routine samples on immunofluorescence. Inhalation of hypertonic saline is probably the best method of obtaining a deep sputum specimen.22 It should be emphasised that the sensitivity of 55-56% in two previous studies was based on results from induced sputum45 whereas our sensitivity of 57% was based mainly on samples that were not induced (13/17). The sensitivity would probably increase if immunofluorescence staining were performed on induced sputum. The method of sampling sputum is safe because it includes inactivation of HIV, and it is easy to perform and sensitive. Hence examination of sputum for P carinii can be used to screen all patients positive for HIV antibody presenting with pulmonary symptoms, thereby lessening the increasingly heavy load on bronchoscopy units and permitting earlier diagnosis and treatment.
Immunocytological staining of pneumocystis by immunofluorescence with 3F6 monoclonal antibody seems to have several advantages compared with conventional cytochemical staining techniques such as that using Grocott's methenamine silver stain, especially when the diagnostic procedure is carried out by units with little previous experience in identifying the parasite.
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Method SAMPLE POPULATION
In 1981 the population of Leicestershire was estimated to be 845 000, of whom about 60000 were of Asian origin. The Asian population (roughly 60% Hindu, 25% Moslem, and 15% Sikh) live predominantly within the city of Leicester. They came mainly from India (Gujerat and Punjab), Kenya, and Uganda. In 1981 women born in the New Commonwealth and Pakistan were responsible for 13% of all Leicestershire births and 32% of births in Leicester city.
The results below relate to the 1342 perinatal deaths in singleton deliveries to Leicestershire women from 1976 to 1985.
STUDY DESIGN
We used a case-control study design with cases defined as perinatal deaths occurring to women whose place of residence was Leicestershire, regardless of the place ofdelivery. Controls were selected as the next live birth to a Leicestershire woman in the intended place of delivery of the perinatal death to which the case related. The study was, therefore, a stratified case-control study, and estimates of relative risk and associated significance tests were calculated with the method of Mantel and Haenszel.7 Case note reviews,
